Sen. Richard Burr is wondering whether industry should demand more protection in the user fee agreement, namely consequences for FDA if the agency does not meet the goals of the user fee agreements.
The North Carolina Republican asked during a recent Senate Health, Education, Labor and Pensions Committee hearing whether FDA should adjust...